Carle Cancer Institute Normal — Normal, Illinois

Carle Cancer Institute Normal is a clinical research site located in Normal, Illinois, United States 61761.

Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.

Carle Cancer Institute Normal has participated in 103 clinical trials with 81 currently active.

Therapeutic areas: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma.

Sponsors: National Cancer Institute (NCI), Wake Forest University Health Sciences, GOG Foundation.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Normal

Browse all research sites in Illinois · View every site in Normal

Sponsor Feasibility Report

Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Carle Cancer Institute Normal?

Carle Cancer Institute Normal has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Carle Cancer Institute Normal conducted?

Carle Cancer Institute Normal has 103 clinical trials on record, with 81 currently active. Their work covers Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma.

Is Carle Cancer Institute Normal accredited by Crixeo Clinical Trials?

Carle Cancer Institute Normal has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Carle Cancer Institute Normal?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.